top of page
+55 68 3342-1047
Segunda a Sexta: 7:00 a 14:00
Perfil
Data de entrada: 12 de mar. de 2024
Sobre
Immunotherapy has become a revolution in the area of cancer treatment. Compared to the traditional methods, such as invasive surgeries, radiation and chemotherapy, immunotherapy is more specific and less toxic to patients. Chimeric antigen receptor (CAR)-engineered T cell therapy is the most promising approach, which has shown remarkable ability to eliminate various kinds of tumors, especially for B cell malignancies, with up to 95% response rates and durable complete remission. Learn more: CAR-T cell therapy
biolabs-marketing
Mais ações
bottom of page